Biopharma earnings analysis and industry outlook

Q1 2021

Download the report 

 

EY’s Life Sciences Quarterly Earnings Report assesses top life sciences companies by market capitalization and examines each company’s earnings, the key themes and drivers from the past quarter and areas to keep an eye on in the coming months.

The team

By Arda Ural, PhD

EY Americas Industry Markets Leader, Health Sciences and Wellness

Co-author of numerous whitepapers and a frequent speaker about biopharmaceutical strategy at industry conferences. Married father of two.

Life Sciences

Architects of better-connected health ecosystems for the Transformative Age.

Learn more

Quarterly report: delivered to your inbox

Sign-up to receive our next quarterly report when it is released.

Subscribe